Masato Murakami, MD, PhD, MBA is President and CEO of PDRadiopharma Inc., Japan’s leading radiopharmaceutical company, and Chief Medical Officer of PeptiDream Inc. He has extensive experience in global drug development across academia and industry. He leads the global development and expansion of peptide-based radiopharmaceuticals and theranostics, integrating discovery platforms with clinical development and manufacturing, and contributes to national initiatives advancing Japan’s radiopharmaceutical ecosystem.
